SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-17-006805
Filing Date
2017-11-17
Accepted
2017-11-17 17:00:21
Documents
2
Period of Report
2017-11-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c11171708k.htm 8-K 25874
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 8575
  Complete submission text file 0001214659-17-006805.txt   35628
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 171211679
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences